Ardelyx reported $468K in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11895M 427M
Amgen AMGN:US $ 6238M 608M
Ardelyx ARDX:US $ 0.47M 0.56M
Astrazeneca AZN:US $ 11390M 621M
Biocept BIOC:US $ 19.94M 5.97M
Chimerix CMRX:US $ 0.02M 0.03M
Corcept Therapeutics CORT:US $ 93.69M 5.13M
Curis CRIS:US $ 2.06M 1.08M
Opko Health OPK:US $ 329.22M 72.11M
Tg Therapeutics TGTX:US $ 2.02M 0.3M
United Therapeutics UTHR:US $ 461.9M 46.7M
Xoma XOMA:US $ 3.11M 32.84M